Cadila Healthcare target price pegged at Rs 600 by Sharekhan, says stock in sweet spot
Cadila Healthcare share price: Sharekhan says that Cadila Healthcare is in a sweet spot as the company’s business in its two key geographies is expected to gain traction. Cadila Healthcare has been outperforming Indian pharmaceutical markets (IPM) growth since the past two quarters, reporting strong double digit growth. US business growth is expected to be driven by a strong product pipeline and growth in the existing business
Sharekhan retains Buy recommendation on Cadila with a revised price target of Rs 600. Cadila Healthcare share price today is Rs 555.3, up Rs 28 or 5.3%: Reuters